login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AGIOS PHARMACEUTICALS INC (AGIO) Stock News
USA
-
Nasdaq
- NASDAQ:AGIO -
US00847X1046
-
Common Stock
29.04
USD
+0.61 (+2.16%)
Last: 11/26/2025, 8:14:56 PM
29.0184
USD
-0.02 (-0.07%)
After Hours:
11/26/2025, 8:14:56 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AGIO Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: Chartmill
- Mentions:
CYN
STEC
KZIA
ZYXI
...
Which stocks are moving on Wednesday?
8 days ago - By: Chartmill
- Mentions:
MVO
KZIA
ZYXI
EZGO
...
Let's have a look at the top gainers and losers in the middle of the day of today's session.
7 days ago - By: Zacks Investment Research
- Mentions:
ALKS
CRMD
FULC
AGIO Stock Hits 52-Week Low on Mixed Sickle Cell Disease Study Results
7 days ago - By: Benzinga
- Mentions:
BRKR
NDAQ
MMC
PSN
...
This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
7 days ago - By: Benzinga
- Mentions:
BRKR
GLOB
BRBR
ORIC
...
This Bellring Brands Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
7 days ago - By: Stocktwits
Agios Pharmaceuticals Stock Suffers Record Wipeout As Wall Street Warns Of 'Uncertain' Regulatory Path For Sickle Cell Drug
8 days ago - By: The Motley Fool
Why Shares in Agios Pharmaceuticals Got Crushed Today
8 days ago - By: Chartmill
- Mentions:
MVO
STEC
KZIA
EZGO
...
Traders are paying attention to the gapping stocks in Wednesday's session.
8 days ago - By: Stocktwits
- Mentions:
VFMO
IWMW
AGIO Stock Cracks After Sickle-Cell Disease Drug Delivers Mixed Results In Late-Stage Trial
8 days ago - By: Chartmill
- Mentions:
PLUG
STEC
TSE
KZIA
...
Wondering what's happening in today's pre-market session?
8 days ago - By: Agios Pharmaceuticals, Inc.
Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease
24 days ago - By: Agios Pharmaceuticals, Inc.
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
a month ago - By: Zacks Investment Research
- Mentions:
BEAM
ANIP
NTLA
AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues
a month ago - By: Agios Pharmaceuticals, Inc.
Agios Reports Third Quarter 2025 Financial Results and Provides Business Update
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
a month ago - By: Agios Pharmaceuticals, Inc.
Agios’ PYRUKYND® (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia
a month ago - By: Agios Pharmaceuticals, Inc.
Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO
2 months ago - By: Schall Law Firm
AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
3 months ago - By: Zacks Investment Research
- Mentions:
ADPT
ALLO
AKRO
AGIO Stock Falls as FDA Delays Decision on Pyrukynd for Thalassemia
Please enable JavaScript to continue using this application.